Literature DB >> 19834287

Alteration in metabolism and toxicity of acetaminophen upon repeated administration in rats.

Sun J Kim1, Min Y Lee, Do Y Kwon, Sung Y Kim, Young C Kim.   

Abstract

Our previous studies showed that administration of a subtoxic dose of acetaminophen (APAP) to female rats increased generation of carbon monoxide from dichloromethane, a metabolic reaction catalyzed mainly by cytochrome P450 (CYP) 2E1. In this study we examined the changes in metabolism and toxicity of APAP upon repeated administration. An intraperitoneal dose of APAP (500 mg/kg) alone did not increase aspartate aminotransferase, alanine aminotransferase, or sorbitol dehydrogenase activity in serum, but was significantly hepatotoxic when the rats had been pretreated with an identical dose of APAP 18 h earlier. The concentrations and disappearance of APAP and its metabolites in plasma were monitored for 8 h after the treatment. APAP pretreatment reduced the elevation of APAP-sulfate, but increased APAP-cysteine concentrations in plasma. APAP or APAP-glucuronide concentrations were not altered. Administration of a single dose of APAP 18 h before sacrifice increased microsomal CYP activities measured with p-nitrophenol, p-nitroanisole, and aminopyrine as probes. Expression of CYP2E1, CYP3A, and CYP1A proteins in the liver was also elevated significantly. The results suggest that administration of APAP at a subtoxic dose may result in an induction of hepatic CYP enzymes, thereby altering metabolism and toxicological consequences of various chemical substances that are substrates for the same enzyme system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834287     DOI: 10.1254/jphs.09151fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

1.  Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity.

Authors:  Darren G N Craig; Caroline M Bates; Janice S Davidson; Kirsty G Martin; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

2.  Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability.

Authors:  Kun Zhang; Xiude Fan; Xiaoyun Wang; Xiaoge Zhang; Lu Zeng; Na Li; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.

Authors:  Alice E Kane; Sarah J Mitchell; John Mach; Aniko Huizer-Pajkos; Catriona McKenzie; Brett Jones; Victoria Cogger; David G Le Couteur; Rafael de Cabo; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-11-23       Impact factor: 4.032

4.  N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice.

Authors:  Alice Elizabeth Kane; Aniko Huizer-Pajkos; John Mach; Catriona McKenzie; Sarah Jayne Mitchell; Rafael de Cabo; Brett Jones; Victoria Cogger; David G Le Couteur; Sarah Nicole Hilmer
Journal:  Fundam Clin Pharmacol       Date:  2016-02-17       Impact factor: 2.748

5.  Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis.

Authors:  Oswald Moling; Lukas Tappeiner; Andrea Piccin; Elisabetta Pagani; Patrizia Rossi; Giovanni Rimenti; Claudio Vedovelli; Peter Mian
Journal:  Med Sci Monit       Date:  2012-07

6.  The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide.

Authors:  Agnieszka Karbownik; Edyta Szałek; Katarzyna Sobańska; Wojciech Połom; Tomasz Grabowski; Anna Biczysko-Murawa; Marcin Matuszewski; Anna Wolc; Edmund Grześkowiak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-03-28       Impact factor: 2.441

7.  Elevated procalcitonin levels in patients with acetaminophen intoxication: two case reports: A CARE-compliant article.

Authors:  Jung Hwan Ahn; Young Suk Cho; Gyu Chong Cho
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.